Factors of ADHD Medication Use Study

Published: 2016-06-09 - Updated: 2021-05-24
Author: University of Michigan | Contact: umich.edu

Main Digest

Youth who take Ritalin, Adderall or other stimulant medications for attention deficit hyperactivity disorder (ADHD) over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a University of Michigan study.

The findings also show that teens who start using stimulant medications for attention deficit hyperactivity disorder for a short time later in adolescence - during middle or high school - are at high risk of substance use..

The U-M research is believed to be the first national study to compare early-use and longer-duration stimulant medication therapy with nonstimulant therapy for ADHD.

A large sample size of high school seniors also meant researchers could separate doctor-prescribed ADHD medication use by gender. The results show no gender differences in the overall associations between stimulant medication therapy for ADHD and risk of substance use, said Sean Esteban McCabe, a research professor at the U-M Institute for Research on Women and Gender.

More than 40,000 individuals from 10 cohorts nationwide between 2005 to 2014, answered questions about ADHD medication use and recent substance use as part of the Monitoring the Future study.

Among the Findings

• Nearly one in eight high school seniors in the U.S. have used stimulant or nonstimulant medication therapy for ADHD.
• Males are more likely to use stimulant medication therapy for ADHD, while no gender differences were found for nonstimulant medication therapy.

Given that higher substance-use behaviors are associated with later initiation of stimulant medications for ADHD during adolescence, the researchers recommend monitoring this later initiation subgroup carefully for pre-existing risk factors or the onset of substance use behaviors.

About the Study

McCabe collaborated with Kara Dickinson, former intern at the U-M Institute for Research on Women and Gender; Brady West, research associate professor at the U-M Institute for Social Research; and Dr. Timothy Wilens of Massachusetts General Hospital and Harvard University.

The findings appear in the current issue of the Journal of the American Academy of Child & Adolescent Psychiatry.

The National Institute on Drug Abuse and National Institutes of Health supported research grants for the study.

Study: www.jaacap.com/article/S0890-8567(16)30099-5/abstract

Primary Information Source(s):

Factors of ADHD Medication Use Study | University of Michigan (umich.edu). Disabled World makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.

You're reading Disabled World. See our homepage for informative disability news, reviews, sports, stories and how-tos. You can also connect with us on social media such as Twitter and Facebook or learn more about Disabled World on our about us page.

Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.

Cite This Page (APA): University of Michigan. (2016, June 9). Factors of ADHD Medication Use Study. Disabled World. Retrieved September 21, 2021 from www.disabled-world.com/medical/pharmaceutical/adhd-meds.php